Striking promotion of the in vitro myeloma monoclonal ımmunoglobulin aggregation by ankaferd hemostat

Kaynakça (13)

1. Beyazit Y, Kurt M, Kekilli M, et al. Evaluation of hemos-tatic effects of Ankaferd as an alternative medicine. Al-tern Med Rev 15: 329-36, 2010
2. Haznedaroglu BZ, Haznedaroglu IC, Walker SL, et al.Ultrastructural and morphological analyses of the invitro and in vivo hemostatic effects of Ankaferd BloodStopper. Clin Appl Thromb Hemost 16: 446-53, 2010
3. Haznedaroglu IC. Molecular Basis of the PleiotropicEffects of Ankaferd Blood Stopper. IUBMB Life (Suppl)61: 290-290, 2009
4. Ak G, Cakir O, Kazancioglu HO, et al. The use of anew hemostatic agent: Ankaferd Blood Stopper in he-mophiliacs. Haemophilia 16: 51-51, 2010
5. Al B, Yildirim C, Cavdar M, et al. Effectiveness of An-kaferd blood stopper in the topical control of activebleeding due to cutaneous-subcutaneous incisions.Saudi Med J 30: 1520-1525, 2009
6. Arslan S, Haznedaroglu IC, Oz B, et al. Endobronchialapplication of Ankaferd blood stopper to control profu-se lung bleeding leading to hypoxemia and hemody-namic instability. Resp Med CME 2: 144-146, 2009
7. Balcik OS, Koroglu M, Cipil H, et al. A Placebo-Cont-rolled, Randomized, Double-Blinded, Cross-Over Pha-se I Clinical Study to Demonstrate Safety of AnkaferdBlood Stopper Topical Usage In Healthy Volunteers.Int J Lab Hem 32(Suppl 1):126-127, 2010
8. Kurt M, Akdogan M, Onal IK, et al. Endoscopic topicalapplication of Ankaferd Blood Stopper for neoplasticgastrointestinal bleeding: A retrospective analysis. DigLiver Dis 42: 196-199, 2010
9. Kurt M, Onal I, Akdogan M, et al. Ankaferd BloodStopper for controlling gastrointestinal bleeding due todistinct benign lesions refractory to conventional anti-hemorrhagic measures. Can J Gastroenterol 24: 380-384, 2010
10. Meric Teker A, Korkut AY, Kahya V, et al. Prospective,randomized, controlled clinical trial of Ankaferd BloodStopper in patients with acute anterior epistaxis. EurArch Otorhinolaryngol 267: 1377-1381, 2010
11. Teker AM, Korkut AY, Gedikli O, et al. Prospective,controlled clinical trial of Ankaferd Blood Stopper inchildren undergoing tonsillectomy. Int J Pediatr Otorhi-nolaryngol 73: 1742-1745, 2009
12. Turhan N, Kurt M, Shorbagi A, et al. Topical AnkaferdBlood Stopper administration to bleeding gastrointes-tinal carcinomas decreases tumor vascularization. AmJ Gastroenterol 104: 2874-2877, 2009
13. Yarali N, Oruc M, Bay A, et al. A new hemostaticagent-Ankaferd blood stopper: Management of gast-rointestinal bleeding in an infant and other experiencesin children. Pediatr Hematol Oncol